Treatment and clinical outcomes of pediatric autoimmune hemolytic anemia: real-world single-center data from Korea
Background Autoimmune hemolytic anemia (AIHA) is rare and characterized by hemolytic anemia with a positive direct antiglobulin test result after the exclusion of other causes. While adults often relapse within 1 year of first-line steroid therapy, children generally respond well. However, current t...
Saved in:
Main Authors: | Young Dai Kwon, Eun Sun Jung, Yeon Jung Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Pediatric Society
2025-07-01
|
Series: | Clinical and Experimental Pediatrics |
Subjects: | |
Online Access: | http://e-cep.org/upload/pdf/cep-2024-02026.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autoimmune Hemolytic Anemia in the Course of Pediatric Acute Leukemia and After Hematopoietic Stem Cell Transplantation
by: Sırma Karamercan, et al.
Published: (2025-07-01) -
Beneath the surface in autoimmune hemolytic anemia: pathogenetic networks, therapeutic advancements and open questions
by: Alessandro Costa, et al.
Published: (2025-07-01) -
Partial Splenic Artery Embolization for Idiopathic Warm Autoimmune Hemolytic Anemia Refractory to Medical Therapy
by: Mohamad Omar Hadied, et al.
Published: (2020-07-01) -
Recurrent COVID-19 induced Warm Autoimmune Hemolytic Anemia
by: Mohammed Abu-Rumaileh, et al.
Published: (2025-06-01) -
Autoimmune hemolytic anemia: the current state of the issue
by: P. I. Vasilchenkova, et al.
Published: (2023-05-01)